How much revenue does Maven Brands make?

Maven Brands reported 0 CAD in revenue for fiscal year 2022. In Q3 2023 revenue was 0 CAD.

What companies are similar to Maven Brands?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Anthera Pharmaceuticals, Inc. (ANTH), Claritas Pharmaceuticals, Inc. (CLAZF), Sproutly Canada Inc. (SRUTF), Rebus Holdings, Inc. (RBSH).

Maven Brands Inc. (TRLFF) Stock

About Maven Brands Inc.

Maven Brands Inc., together with its subsidiary, engages in the production, toll-processing, and packaging of medical cannabis in Canada. It is also involved in the provision of regulatory support and QA services; supply contract services for co-branded and distribution; microbial and analytics services; genetic cleaning, propagation, cloning, and bio-banking services; and land package services fo...

At a glance

Maven Brands reported revenue of 0 CAD for fiscal year 2022, and net income of -2.46 million CAD. In Q3 2023 (the quarter ended December 31, 2022) revenue was 0 CAD, down 100.0% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2022.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.